Hemolytics
Hemolytics is a MedTech company that develops a chemical amplification method for ultrasensitive detection of malaria.
Hemolytics is a business in biotechnology, health care, medical, medical device based in Europe, Middle East, and Africa (EMEA), founded in 2017.
Its activity falls under biotechnology, health care, medical, medical device; the profile below is assembled from public directory data.
The company is recorded as being based in Europe, Middle East, and Africa (EMEA).
The company is listed at the Grant stage of development.
Its team size is recorded as c_00001_00010 employees.
Public records show total funding of about $1K.
| Sector | Biotechnology, Health Care, Medical, Medical Device |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2017 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $10,000 |
Website: www.hemolytics.ch
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account